Repaglinide 0.5mg, 1mg, 2mg Tablets
Last Updated on eMC 27-Jun-2016 View document | Actavis UK Ltd Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 27-Jun-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 6 - date of revision
Updated on 16-Nov-2015 and displayed until 27-Jun-2016
Reasons for adding or updating:
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 06-Jul-2011 and displayed until 16-Nov-2015
Reasons for adding or updating:
- Introduction of new pack/pack size
Updated on 23-Jun-2011 and displayed until 06-Jul-2011
Reasons for adding or updating:
- New PIL for new product
Actavis UK Ltd
Actavis UK Ltd, a subsidiary of Accord Healthcare Ltd, Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK
+44 (0)1271 346 106
+44 (0)1271 311 200
+44 (0)1271 385 257
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue